| Description: |
Not all receptor antagonist that bind to enzymes are inhibitors, Since blocking an enzyme's activity can kill a pathogen , activator, caspase, esterase inhibitors , lipoprotein, many drugs are enzyme inhibitors, papain, pathway, peptidase, protease , proteinase, trypsin, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme, , Tissue, acrosin, activity, and decreases its , are , bind to enzymes and increase their , enzymatic activity, enzyme activator ligands or agonists , enzyme receptor , imbalance, metabolic , or correct a , or receptor ligands or receptor antagonists that bind to an , proteins |
| Alternative to gene target: |
BPIFF and HDLCQ10, CETP and IDBG-32674 and ENSG00000087237 and 1071, Extracellular, phosphatidylcholine binding, plasma, this GO :0005319 and lipid transporter activity and molecular function this GO :0005548 and phospholipid transporter activity and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0006898 and receptor-mediated endocytosis and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0010745 and negative regulation of macrophage derived foam cell differentiation and biological process this GO :0010874 and regulation of cholesterol efflux and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0015914 and phospholipid transport and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0017129 and triglyceride binding and molecular function this GO :0030301 and cholesterol transport and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031982 and vesicle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034372 and very-low-density lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042632 and cholesterol homeostasis and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0046470 and phosphatidylcholine metabolic process and biological process this GO :0055088 and lipid homeostasis and biological process this GO :0055091 and phospholipid homeostasis and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070328 and triglyceride homeostasis and biological process, this GO :0005319 : lipid transporter activity, this GO :0005319 : lipid transporter activity and also this GO :0005548 : phospholipid transporter activity and also this GO :0008289 : lipid binding and also this GO :0015485 : cholesterol binding and also this GO :0017127 : cholesterol transporter activity and also this GO :0017129 : triglyceride binding and also this GO :0031210 : phosphatidylcholine binding, this GO :0005548 : phospholipid transporter activity, this GO :0008289 : lipid binding, this GO :0015485 : cholesterol binding, this GO :0017127 : cholesterol transporter activity, this GO :0017129 : triglyceride binding, this GO :0031210 : phosphatidylcholine binding, cholesteryl ester transfer protein |